help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baxter, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baxter, R. C.

Endocrinology, Vol 117, 650-655, Copyright © 1985 by Endocrine Society


ARTICLES

Measurement of growth hormone and prolactin receptor turnover in rat liver

RC Baxter

To study the rate of disappearance of GH and PRL receptors in the livers of rats treated with cycloheximide, a technique has been devised for multiple sampling from the liver of each anesthetized rat. In rats treated with cycloheximide (1 or 5 mg/kg, iv), binding sites for both bovine GH and ovine PRL disappeared following first order kinetics over the 2-h sampling period. The half-time for the GH receptor was 30-40 min, equivalent to a rate constant of approximately 0.02 min-1. The half-time for the PRL receptor was 40-50 min, equivalent to a rate constant of approximately 0.015 min-1. At 0.1 mg/kg cycloheximide, slower disappearance rates were seen for both receptors, and the GH receptor showed a partial recovery. Over the same period, binding sites for insulin were unaltered at any cycloheximide dose. Assuming cycloheximide acts simply to inhibit new receptor synthesis, these rates represent the turnover time for GH and PRL receptors in rat liver.


This article has been cited by other articles:


Home page
EndocrinologyHome page
T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson
Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans
Endocrinology, September 1, 2004; 145(9): 4162 - 4175.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. van Kerkhof, M. Smeets, and G. J. Strous
The Ubiquitin-Proteasome Pathway Regulates the Availability of the GH Receptor
Endocrinology, April 1, 2002; 143(4): 1243 - 1252.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. van Kerkhof, R. Govers, C. M. Alves dos Santos, and G. J. Strous
Endocytosis and Degradation of the Growth Hormone Receptor Are Proteasome-dependent
J. Biol. Chem., January 21, 2000; 275(3): 1575 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Defalque, N. Brandt, J.-M. Ketelslegers, and J.-P. Thissen
GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors
Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E565 - E572.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Govers, P. van Kerkhof, A. L. Schwartz, and G. J. Strous
Di-leucine-mediated Internalization of Ligand by a Truncated Growth Hormone Receptor Is Independent of the Ubiquitin Conjugation System
J. Biol. Chem., June 26, 1998; 273(26): 16426 - 16433.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. P. Frick, L.-R. Tai, W. R. Baumbach, and H. M. Goodman
Tissue Distribution, Turnover, and Glycosylation of the Long and Short Growth Hormone Receptor Isoforms in Rat Tissues
Endocrinology, June 1, 1998; 139(6): 2824 - 2830.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society